Innovations in Implementing Decentralized HIV Services in Peru

秘鲁实施分散式艾滋病毒服务的创新

基本信息

  • 批准号:
    10762842
  • 负责人:
  • 金额:
    $ 72.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-06 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Despite successes in diagnosing and initiating antiretroviral therapy (ART) in people with HIV (PWH) in Peru, a LMIC with an HIV epidemic concentrated in key at-risk populations, the implementation gap is highest for retention in care (RIC), resulting in low levels of viral suppression (43%) and increasing HIV incidence. HIV care in Peru is currently concentrated in large secondary health centers (SHCs). Based on WHO recommendations to decentralize healthcare, an evidence-based practice that increases RIC, the Peruvian Ministry of Health recommended in 2019 to decentralize HIV services to primary health centers (PHCs). We propose to work in the 4 largest regions in urban Lima that manages 37% of all PWH in care. Currently, <15% of PWH in Lima receive care in PHCs, supporting the need for more effective implementation of decentralized services. Using the RE- AIM implementation framework, we propose to accelerate decentralization by combining NIATx, an evidence- informed implementation strategy with a bundle of implementation tools to scale up evidence-based practices, with Project ECHO, an evidence-informed tele-educational strategy to increase clinical skills in primary care providers to competently provide specialty (i.e., HIV) services. We will first use the Delphi method to establish guidelines to safely decentralize PWH using a hub (SHC) and spoke (PHC) model and to establish the minimal number of quality health indicators that are needed to safely keep patients in PHCs. These guidelines can be used to create clinical checklists that can be used to support guideline concordance in clinical practice. We will then conduct a rapid, multi-level (patients, clinicians, healthcare system) assessment of barriers and facilitators to decentralizing HIV care, which will be assessed just before each of the four hub and spoke regions will be randomized to 24 months of implementation using NIATx and ECHO in a stepped wedge design. The primary effectiveness outcome will be proportionate change of PWH receiving HIV care in PHCs. Secondary outcomes include RIC and VS with exploratory analyses for mortality. The primary implementation outcomes are confidence in managing PWH at PHCs. Collaboration, workplace climate and adoption of HIV care at new PHC sites will be measured within each hub and spoke. Adoption of HIV care at new PHCs in each region will be assessed. Importance is high due to the MoH’s goal to decentralize HIV care in an urban, low/middle income setting where HIV is concentrated in key populations with low levels of RIC and VS levels. Innovation is high due to combining NIATx and ECHO in an urban South American context and using them beyond addiction treatment. Feasibility is high due to the longstanding relationships between team members alongside the strong commitment by the Ministry of Health. The team brings expertise in HIV care (Sanchez, Altice), Public Health (Konda, Altice), implementation science (Altice, Madden, Konda) and service integration (Altice, Madden). Public Health benefit is high not only in terms of systems-, clinician- and patient-level benefits through implementing decentralized care in Peru, but also serves as a template for other urban, low/middle income settings.
尽管在秘鲁患有艾滋病毒(PWH)的患者的诊断和抗逆转录病毒疗法(ART)方面取得了成功,但 LMIC患有HIV流行的LMIC集中在关键高危人群中,实施差距最高 保留护理(RIC),导致病毒抑制水平较低(43%)和HIV入口增加。艾滋病毒护理 目前,秘鲁集中在大型中学中心(SHC)中。根据谁的建议 为了分散医疗保健,这是一种基于证据的实践,以增加秘鲁卫生部RIC 推荐于2019年将艾滋病毒服务分散到初级卫生中心(PHCS)。我们建议在 城市利马市的4个最大地区,管理着所有PWH的37%。目前,利马的PWH <15%接受 PHC的护理,支持更有效地实施分散服务。使用重新 AIM实施框架,我们建议通过结合Niatx(证据)来加速权力下放化。 通过一系列实施工具来扩展基于证据的实践的知情实施策略, 通过Project Echo,一种有证据的电信教育策略来提高初级保健的临床技能 提供者能够有能力提供专业(即艾滋病毒)服务。我们将首先使用Delphi方法来建立 使用轮毂(SHC)和辐条(PHC)模型安全分散PWH的准则,并建立最小的 确保将患者保留在PHC中所需的质量健康指标数量。这些准则可能是 用于创建可用于支持临床实践中的指南协和的临床清单。我们将 然后对障碍和促进者进行快速的多层次(患者,临床医生,医疗系统)评估 分散艾滋病毒护理,将在四个枢纽和辐条区域中的每个枢纽之前进行评估 在阶梯楔形设计中,使用Niatx和Echo随机分配到24个月的实施。主要 有效性结果将是PHC中接受HIV护理的PWH的比例变化。次要结果 包括RIC和VS具有探索性分析的死亡率。主要实现结果是 对在PHCS管理PWH的信心。在新的PHC上的合作,工作场所气氛和采用艾滋病毒护理 站点将在每个集线器中测量并发言。在每个地区的新PHC中采用艾滋病毒护理将是 评估。重要性很高,因为卫生部的目标是在城市,低/中间收入中分散艾滋病毒护理 艾滋病毒集中在RIC和VS水平较低的关键种群中。创新很高 在南美城市的环境中结合Niatx和Echo,并使用它们不仅成瘾治疗。 由于团队成员之间的长期关系以及强大的强大关系,可行性很高 卫生部的承诺。该团队带来了艾滋病毒护理(Sanchez,Altice),公共卫生的专业知识 (Konda,Altice),实施科学(Altice,Madden,Konda)和服务整合(Altice,Madden)。民众 健康益处不仅在系统,临床和患者水平的福利方面都很高 秘鲁的分散护理,但也是其他城市,低/中收入环境的模板。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

FREDERICK LEWIS AL...的其他基金

Prison Interventions and HIV Prevention Collaboration
监狱干预和艾滋病毒预防合作
  • 批准号:
    10548569
    10548569
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention
使用快速启动抗逆转录病毒治疗干预措施减少艾滋病毒注射者的耻辱
  • 批准号:
    10756389
    10756389
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Georgian Implementation Science Fogarty Training Program (GIFT)
格鲁吉亚实施科学福格蒂培训计划 (GIFT)
  • 批准号:
    10688700
    10688700
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Expanding Medication Assisted Therapies in Central Asia
在中亚扩大药物辅助治疗
  • 批准号:
    10693856
    10693856
  • 财政年份:
    2022
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Expanding Medication Assisted Therapies in Central Asia
在中亚扩大药物辅助治疗
  • 批准号:
    10403273
    10403273
  • 财政年份:
    2022
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
将成瘾和传染病服务纳入农村地区的初级保健
  • 批准号:
    10670120
    10670120
  • 财政年份:
    2021
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
将成瘾和传染病服务纳入农村地区的初级保健
  • 批准号:
    10311425
    10311425
  • 财政年份:
    2021
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
将成瘾和传染病服务纳入农村地区的初级保健
  • 批准号:
    10453688
    10453688
  • 财政年份:
    2021
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Malaysian Implementation Science Training (MIST) Program in HIV
马来西亚艾滋病毒实施科学培训(MIST)计划
  • 批准号:
    10358577
    10358577
  • 财政年份:
    2020
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia
对阿片类激动剂治疗的影响和成本效益进行建模,以减少监禁对东欧和中亚艾滋病毒和结核病传播的负面影响
  • 批准号:
    10013670
    10013670
  • 财政年份:
    2020
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer
创建癌症体细胞变异临床可行性的高质量断言知识库
  • 批准号:
    10555024
    10555024
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
  • 批准号:
    10726660
    10726660
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Unified, Scalable, and Reproducible Neurostatistical Software
统一、可扩展且可重复的神经统计软件
  • 批准号:
    10725500
    10725500
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
The WUSTL PREP post-bacc program to enhance doctoral readiness in neuroscience
WUSTL PREP post bacc 项目旨在提高神经科学博士的准备程度
  • 批准号:
    10611674
    10611674
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别:
Signature Research Project
签名研究项目
  • 批准号:
    10577120
    10577120
  • 财政年份:
    2023
  • 资助金额:
    $ 72.36万
    $ 72.36万
  • 项目类别: